Literature DB >> 25586674

Profile of plasma amino acids values as a predictor of sepsis in patients following living donor liver transplantation: Special reference to sarcopenia and postoperative early nutrition.

Takeo Toshima1, Ken Shirabe1, Takeshi Kurihara1, Shinji Itoh1, Norifumi Harimoto1, Toru Ikegami1, Tomoharu Yoshizumi1, Hirofumi Kawanaka1, Tetsuo Ikeda1, Yoshihiko Maehara1.   

Abstract

AIM: Sarcopenia is an independent predictor of mortality and sepsis after living donor liver transplantation (LDLT). However, the exact mechanisms by which sarcopenia affects poor prognosis or worse immunity against postoperative sepsis are unclear, particularly regarding muscular amino acid metabolism, and the authors aimed to identify the role of plasma amino acids in sarcopenia by retrospective study.
METHODS: The area of the psoas muscle in 228 recipients of LDLT was retrospectively measured by dynamic computed tomography. Additionally, plasma amino acid levels were measured both pre- and postoperatively. The impact of plasma amino acids for postoperative sepsis and the relationship between sarcopenia and early nutrition after LDLT were analyzed.
RESULTS: Among the plasma amino acids, only leucine, isoleucine and glutamine in patients with sarcopenia were significantly lower than those without sarcopenia (each, P < 0.05). Multivariate analysis identified the lower plasma glutamine levels as a risk factor of postoperative sepsis after LDLT (odds ratio 5.371, P = 0.002). In sarcopenia patients, plasma glutamine levels after LDLT were significantly decreased compared with before LDLT in patients both with and without postoperative early nutrition. However, in non-sarcopenia patients with early nutrition, plasma glutamine levels after LDLT were comparable with those before LDLT.
CONCLUSION: This is the first report to study the profile of plasma amino acid change before and after LDLT. Low preoperative glutamine values were an independent risk factor for predicting postoperative sepsis. The efficacy of postoperative early nutrition may prevent postoperative sepsis by improving glutamine levels.
© 2015 The Japan Society of Hepatology.

Entities:  

Keywords:  amino acid; glutamine; liver transplantation; sarcopenia; sepsis

Year:  2015        PMID: 25586674     DOI: 10.1111/hepr.12484

Source DB:  PubMed          Journal:  Hepatol Res        ISSN: 1386-6346            Impact factor:   4.288


  10 in total

1.  A reliable LC-MS/MS method for the quantification of natural amino acids in mouse plasma: Method validation and application to a study on amino acid dynamics during hepatocellular carcinoma progression.

Authors:  Zhenzhen Liu; Mei-Juan Tu; Chao Zhang; Joseph L Jilek; Qian-Yu Zhang; Ai-Ming Yu
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2019-06-02       Impact factor: 3.205

2.  A multicenter study to define sarcopenia in patients with end-stage liver disease.

Authors:  Elizabeth J Carey; Jennifer C Lai; Connie W Wang; Srinivasan Dasarathy; Iryna Lobach; Aldo J Montano-Loza; Michael A Dunn
Journal:  Liver Transpl       Date:  2017-05       Impact factor: 5.799

3.  Sarcopenia in Liver Transplantation.

Authors:  John Montgomery; Michael Englesbe
Journal:  Curr Transplant Rep       Date:  2019-01-21

Review 4.  Amino acid supplements and metabolic health: a potential interplay between intestinal microbiota and systems control.

Authors:  Francesco Bifari; Chiara Ruocco; Ilaria Decimo; Guido Fumagalli; Alessandra Valerio; Enzo Nisoli
Journal:  Genes Nutr       Date:  2017-10-04       Impact factor: 5.523

5.  Increased plasma proline concentrations are associated with sarcopenia in the elderly.

Authors:  Kenji Toyoshima; Marie Nakamura; Yusuke Adachi; Akira Imaizumi; Tomomi Hakamada; Yasuko Abe; Eiji Kaneko; Soiciro Takahashi; Kentaro Shimokado
Journal:  PLoS One       Date:  2017-09-21       Impact factor: 3.240

6.  Risk Factors for Sepsis Based on Sepsis-3 Criteria after Orthotopic Liver Transplantation.

Authors:  Yanling Wang; Yu Gu; Fei Huang; Dezhao Liu; Zheng Zhang; Niman Zhou; Jiani Liang; Changyin Lu; Dongdong Yuan; Ziqing Hei
Journal:  Mediators Inflamm       Date:  2018-06-20       Impact factor: 4.711

7.  The impact of sarcopenia on short-term and long-term mortality in patients with septic shock.

Authors:  Hyung Jung Oh; Jung Ho Kim; Hye Rim Kim; Jin Young Ahn; Su Jin Jeong; Nam Su Ku; Jun Yong Choi; Joon-Sup Yeom; Young Goo Song
Journal:  J Cachexia Sarcopenia Muscle       Date:  2022-04-27       Impact factor: 12.063

Review 8.  Acute Sarcopenia Secondary to Hospitalisation - An Emerging Condition Affecting Older Adults.

Authors:  Carly Welch; Zaki K Hassan-Smith; Carolyn A Greig; Janet M Lord; Thomas A Jackson
Journal:  Aging Dis       Date:  2018-02-01       Impact factor: 6.745

9.  Progressive loss of muscle mass could be an adverse prognostic factor of 28-day mortality in septic shock patients.

Authors:  Dong-Woo Seo; Kyung Won Kim; Chang Hwan Sohn; Seung Mok Ryoo; Youn-Jung Kim; Ahn Shin; Won Young Kim
Journal:  Sci Rep       Date:  2019-11-11       Impact factor: 4.379

10.  Signatures and Clinical Significance of Amino Acid Flux in Sarcopenia: A Systematic Review and Meta-Analysis.

Authors:  Miao Dai; Taiping Lin; Jirong Yue; Lunzhi Dai
Journal:  Front Endocrinol (Lausanne)       Date:  2021-09-13       Impact factor: 5.555

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.